Drugs & Targets DelMar collaborates with Duke to study VAL-083 as front-line GBM treatment April 28, 2017Vol.43 No.17
In Brief SU2C awards $1 million to four research teams through Phillip A. Sharp Awards April 28, 2017Vol.43 No.17
In Brief Cold Spring Harbor to collaborate with Chan Zuckerberg Initiative April 28, 2017Vol.43 No.17
In Brief Kimberly Stegmaier wins St. Baldrick’s Foundation Arceci Innovation Award April 28, 2017Vol.43 No.17
In Brief Western IRB, Huron form alliance to serve research programs at academic centers April 28, 2017Vol.43 No.17
Conversation with The Cancer Letter No future collaborations with NantHealth are planned, U of Utah says April 28, 2017Vol.43 No.17
Tom Curran: Contract between NantHealth and U of Utah “seems a bit expensive” April 28, 2017Vol.43 No.17By Tom Curran
